The possibility for more infectious and deadly variants appears endless – it will take a number of measures and innovations to subdue Covid-19 in future

With first doses for the over-65s and at-risk groups almost completed, new guidelines on vaccines should not greatly disrupt the programme

Deputy chief medical officer says maintaining high level of public confidence in vaccine rollout is crucial

When the incidence of Covid-19 is low, the potential harms to 20-29 year olds from the vaccine outweighed the benefits of preventing ICU admissions through vaccination, the MHRA found

New data has led to a change in policy across Europe on which age cohorts are safe to receive the AstraZeneca vaccine after reports emerged of rare blood clotting events. Will it affect Ireland’s vaccine rollout?

For all the gnashing of teeth over schools and vaccinations, the figures show that the vaccine delivery rate is set to surpass projections by a distance

Some argue that Ireland’s prudence in suspending rollout over the blood clot issue will boost public confidence in vaccination. Others say it may cost lives

Brian MacCraith, chairman of the high-level taskforce on Covid-19 vaccination, has his work cut out in coordinating all bodies involved in the rollout

Tough talk between political leaders and states will not increase the supply of vaccines, a more collaborative approach is needed instead

Minister for Health admits concern after HSE misses last week’s target of 100,000 doses due to pharma company’s delay

Move could result in vaccines being administered to the public at local pharmacies by the end of March

The over-80s benefited most with the weekly average for new cases falling more

Tánaiste says rollout to older people will be slower following recommendation that Pfizer and Moderna vaccines, rather than AstraZeneca, should be used for this group

While AstraZeneca is interpreting its contractual responsibilities to the detriment of the EU, the European Commission is making matters worse by banning the export of vaccines from member states

By underestimating the logistics of a mass vaccination rollout, European leaders risk failing their citizens on this vital issue

So-called ‘vaccine nationalism’ means richer countries have a surplus at the expense of poorer nations

Decades of trust are being wiped away in the row over critical vaccine supplies

Vaccination rollout suffers ‘real’ setback due to AstraZeneca production issues whilst schools look set to remain shut for weeks as talks to continue on students with special needs

The science community’s response to the pandemic has been nothing short of inspirational – and will hopefully encourage the next generation of Stem professionals